About this episode
Daniel Griffin provides a clinical report on COVID-19, review of the phase I and II trials of the Russian prime-boost vaccine, a mouse model that recapitulates age-dependent severe disease, and listener questions.
Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, and Rich Condit
Guest: Daniel Griffin
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Safety and immunogenicity of Russian COVID-19 vaccine (Lancet)
- 'Questionable' data in Russian vaccine results (Nature)
- Mouse model for SARS-CoV-2 ALI and mortality (Cell)
- Letters read on TWiV 667
- Letters to Humans
- Timestamps by Jolene. Thanks!
Weekly Science Picks
Dickson - Rewilding Europe
Alan - How to Do Nothing by Jenny Odell
Rich - Gene drive engineered mosquitoes
Vincent - TWiEVO 60 with 12 guests!
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology